Page 2 - Diabetes

Diwali sugar spike? Here's how to manage sugar without missing the sweets

Diwali's festive feasts can spell trouble for blood sugar, but they don't have to. Nutritionists share simple swaps, mindful eating tips and portion tricks for safe indulgence.

Biocon Biologics expands Civica tie-up to launch pvt-label insulin in US

The move aims to increase the availability of affordable insulin for the country's 38.4 million diabetes patient

All carbs, little protein: How rice, roti, sugar are hurting India's health

ICMR survey shows 62 per cent of Indian calories come from carbs, linking rice, roti and sugar to rising diabetes, obesity and why adding more protein could reverse the trend

Astronauts with diabetes may soon travel safely to space, finds study

Astronauts with diabetes may soon be able to undertake space missions safely, a study conducted during Shubhanshu Shukla's travel to the International Space Station has found. The Suite Ride experiment, conducted by UAE-based healthcare firm Burjeel Holdings during the Axiom-4 mission, found that everyday diabetes tools used by millions on Earth can be used comprehensively to provide end-to-end diabetes monitoring from space to ground and back to space. "This historic advancement opens the door to future astronauts with diabetes and provides new solutions in remote healthcare," a statement from Burjeel Holdings said. The results of the study were announced at the Burjeel Institute for Global Health, New York, in the presence of Shamsheer Vayalil, founder of Burjeel Holdings and Tejpaul Bhatia, CEO, Axiom Space. As per the research results, continuous glucose monitors (CGMs), a wearable medical device tracking blood sugar levels in real time, and insulin pens can operate reliably in

Small steps, big impact: WHO's 'Best Buys' to fight deadly NCDs worldwide

A new WHO report urges governments around the world to adopt low-cost, high-impact steps to curb heart disease, cancer, diabetes and more, warning that delay will cost lives and strain economies

Why brushing at night may be the cheapest way to cut long-term health risks

Doctors warn that skipping your nightly brush may silently fuel diabetes, heart disease, and chronic inflammation-here's why two minutes before bed could change your health trajectory

Cannabis use may quadruple diabetes risk within five years, warns study

A massive study of over 4 million adults finds cannabis users face fourfold risk of type 2 diabetes within five years, raising new questions on its safety profile

It's not just cancer: Smoking may trigger all types of type-2 diabetes

From insulin resistance to insulin deficiency, smoking raises the risk of every type-2 diabetes form - and the more you smoke, the worse it gets, says new study

Undiagnosed diabetes poses major global health risk, warns new study

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

Nearly 44% of diabetics undiagnosed in 2023, India sees 14% rise: Study

About 44 per cent of the world's diabetics were undiagnosed in 2023, while underdiagnosis and sub-optimal management of glycaemic index continue to pose major challenges in low- and middle-income countries, according to an analysis. Estimates published in The Lancet Diabetes and Endocrinology journal show that 43.6 per cent of India's diabetic population were diagnosed with the condition in 2023, an increase of about 14 per cent in diagnosis rates seen in 2000. Over 97 per cent of those diagnosed were under treatment in 2023, an international team of researchers forming the 'Global Burden of Disease' (GBD) study found. More than 55 per cent of people aged 15 and above around the world were diagnosed with diabetes, the analysis of data collected during 2000-2023 from across 204 countries and territories revealed. "By 2050, 1.3 billion people are expected to be living with diabetes, and if nearly half don't know they have a serious and potentially deadly health condition, it could ..

Pharma market grows 8.7% in August; cardiac and anti-diabetic segments lead

The Indian Pharma Market grew 8.7% in August 2025, with the cardiac, anti-diabetic, and anti-neoplastic segments driving growth. Sun Pharma maintained its leadership position

Nocturia: Understanding night-time urination, causes and its solutions

Frequent urination at night is common but not always harmless. Doctors highlight the risks, underlying causes, and practical steps you can take to improve sleep and protect your health

Why it's harder to burn fat with age, and how scientists plan to fix it

Ageing slows our body's natural calorie burners, but a new study shows how reactivating beige fat could help tackle weight gain, diabetes, and heart disease

Will this court fight make the world's hottest weight-loss drug cheaper?

Indian pharma takes Novo Nordisk to court over patents that keep Wegovy and Ozempic out of reach - could this slash prices for millions of patients?

Why men are more likely to die from diabetes, hypertension and HIV

A global study in PLOS Medicine shows men have higher death rates from diabetes, hypertension and HIV/AIDS, largely due to risky lifestyles and lower healthcare use

Eating French fries often raises diabetes risk, Harvard study warns

A study tracking 200,000 US adults reveals eating French fries three times a week can increase type 2 diabetes risk by 20% while boiled or baked potatoes show no such link when eaten in moderation

Ozempic, other weight-loss drugs tied to rare, serious eye issue: Study

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood flow to the optic nerve is suddenly reduced or blocked

Inflammation control in diabetics may cure depression, methods vary: Study

An analysis has revealed that addressing inflammation in diabetes can help determine success in treating depression in a group of patients. However, there are differences in outcomes between type 1 and type 2 diabetes, researchers said. While type 2 diabetes is a metabolic condition marked by an inability to manage blood sugar, type 1 diabetes is an autoimmune disorder in which the body's immune system mistakenly attacks and damages insulin-producing cells in the pancreas. "People with type 2 diabetes and high inflammation levels possibly respond particularly well to a change in depressive cognitions through cognitive behavioural therapy. People with type 1 diabetes and high inflammation levels, on the other hand, could benefit more from anti-inflammatory drug therapies," said author Norbert Hermanns from the Research Institute of the Diabetes Academy Mergentheim (FIDAM), Germany. Findings published in the journal Diabetologia could help develop customised treatment plans for ...

One-fifth of Indians aged 45 and above had diabetes in 2019: Study

About a fifth of those aged 45 and above were living with diabetes in 2019, with two in every five possibly unaware of their condition, according to data from a study among India's ageing adults. Findings published in The Lancet Global Health also suggest that as the country's population rapidly ages, diabetes cases among the middle-aged and older adults will increase, even if increase in prevalence of the condition in age-specific groups can be arrested, authors said. Researchers, including those from the International Institute for Population Sciences, Mumbai, and US, also found that 46 per cent of those aware of their diabetes regained a control over blood sugar levels, while around 60 per cent were able to control their blood pressure the same year. Six per cent were taking a lipid-lowering medication to reduce the risk of cardiovascular disease, the team said. The 'Longitudinal Aging Study in India' (LASI), which surveyed about 60,000 adults aged 45 and above during 2017-2019

Weighty issues: India's rush to make weight-loss drugs demands user caution

The global market for weight-loss drugs is estimated at $100 billion by the end of the decade